Hypertrophic osteoarthropathy in Eisenmenger syndrome.
Hypertrophic osteoarthropathy secondary to Eisenmenger syndrome can produce severe disabling pain. We report two cases treated by intravenous pamidronate infusion with good symptomatic relief. Such therapy can greatly improve the quality of life of end-stage cyanotic congenital heart patients.
Adult Congenital Heart Disease Unit, The Prince Charles Hospital, Brisbane, Queensland, Australia.
Vishva A
VA
Wijesekera
Dorothy J
DJ
Radford
D000328:Adult; D050071:Bone Density Conservation Agents / Q000008:administration & dosage; D004164:Diphosphonates / Q000008:administration & dosage; D004541:Eisenmenger Complex / Q000150:complications* / Q000175:diagnosis; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D010005:Osteoarthropathy, Secondary Hypertrophic / Q000175:diagnosis / Q000209:etiology*; D010146:Pain / Q000209:etiology / Q000517:prevention & control; D000077268:Pamidronate; D016896:Treatment Outcome
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D000077268:Pamidronate